Funding
← Back to your selection

Merck Global Health Innovation Fund

Activity from announced rounds

Activity in this selectionNorth America

Merck Global Health Innovation Fund is the US Merck/MSD investment fund identified in N-Power and Merck Digital Sciences Studio material.

Recorded funding activity

N-Power combines oncology care with trial-data services. DropGenie miniaturizes gene-editing workflows, while Infinimmune develops antibody medicines. The fund remains separate from the Merck parent and Germany’s Merck and M Ventures.

Sources
Rounds participated in
4
Confirmed lead rounds
0
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$182M
3 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1
Series B1
Series C+1

By primary sector

Biotech3
Healthtech1

By country

United States3
Canada1

Rounds

4 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
N-Power Medicine

N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.

$32MSeries B
Participant
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries A
Role not disclosed
DropGenie

Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery

Role not disclosed